TNF and Alzheimer disease: Overall, they found that these NPs were associated with a reduced level of Ab, ROS, TNF-a, and IL-6, and increased activity of superoxide dismutase (SOD) and synapse numbers in AD mouse brains, leading to their potential therapeutic use in AD.